Article Information
History
- March 6, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Simon P Keam1,2,4,*,
- Heloise Halse2,*,
- Thu Nguyen2,
- Minyu Wang2,
- Nicolas Van Kooten Losio2,
- Catherine Mitchell3,
- Franco Caramia1,
- David J Byrne3,
- Sue Haupt1,4,
- Georgina Ryland3,
- Phillip K Darcy2,4,
- Shahneen Sandhu5,
- Piers Blombery3,4,
- Ygal Haupt1,4,6,
- Scott G Williams7,# and
- Paul J Neeson2,4,#,†
- 1Tumor Suppression Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia
- 2Cancer Immunology Research, Peter MacCallum Cancer Centre, Melbourne, Australia
- 3Pathology Department, Peter MacCallum Cancer Centre, Melbourne, Australia
- 4Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia
- 5Genitourinary Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia
- 6Department of Biochemistry and Molecular Biology, Monash University, Australia
- 7Division of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
- ↵†Corresponding author:
Paul J Neeson, Cancer Immunology Research, Peter MacCallum Cancer Center, 305 Grattan St, Parkville, Melbourne, 3000, Australia. Phone: +61 03 85597101, FAX: +61 03 85595459., E-mail: paul.neeson{at}petermac.org
Author contributions S.P.K., H.H., S.G.W. and P.J.N conceived and designed the study. S.P.K., H.H., T.N., N.V.K.L., D.J.B. and G.R. performed experiments. S.P.K., M.W. and F.C. performed bioinformatic and statistical analyses. C.M. performed uropathological inspection. S.P.K. and P.J.N. drafted the manuscript. S.P.K., H.H., P.J.N., SH., Y.H., C.M., D.B., G.R., P.K.D., S.S. and P.B. critically revised the manuscript.
Posted March 06, 2020.
High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot
